Thursday, August 10, 2006

Amgen wins protection for anemia drug

Amgen, Inc., the world’s largest biotechnology firm and Tech-Collective member, was featured in The Boston Globe on August 4, 2006 in a story by Bloomberg News regarding its recent win of an appeals court ruling to keep Shire Plc's Dynepo anemia drug out of the US market. [Read More in The Boston Globe]

For more on Amgen, Inc., Click here.

** Remember, that Tech Collective urges members of the technology industry to not only read and post their thoughts on material we provide in our blog, but to also feel free to post issues and topics of their own for others to respond to.**

Wednesday, August 02, 2006

State Science and Technology Institute’s Article--Senate Appropriators Finally Concur on ATP Demise

Tech-Collective

The July 24, 2006 issue of the State Science and Technology Institute’s Weekly Digest published an article regarding the Senate Appropriations Committee and its decision to terminate the Advanced Technology Program. According to the ATP’s website:

"ATP helps industry invest in longer-term, high risk research with payoffs far beyond private profit. By sharing the cost with companies, ATP accelerates the development of early-stage, innovative technologies, helping industry raise its competitive potential while providing Americans with a higher standard of living."

The following is the State Science and Technology Institute’s article from its weekly digest. Feel free to leave your thoughts on this topic:

Supporters of NIST's Advanced Technology Program (ATP) have weathered years of attempts by members of the House and the Bush Administration to eliminate the program, but this may be the biggest hurdle yet: The Senate Appropriations Committee approved language calling for the program's termination as part of the Department of Commerce fiscal year 2007 appropriations. The first of only two ATP-related sentences included in the Senate Committee report 109-580 accompanying H.R. 5672 conveys the weariness of the battle as the Committee conveys their defeat: "The Committee will allow for the phase out of activities for ATP. No funds are provided in fiscal year 2007 for ATP, and the Committee believes that sufficient funds were provided as part of fiscal year 2006 under this title to cover all necessary close out costs associated with ATP." The Bush Administration has repeatedly called for the program's termination and the House of Representatives has often agreed. Program supporters have always counted on some funding in the Senate's version of the bill and strong pressure in conference to continue the program. It would now take an amendment to restore funding in H.R. 5672 if and when the full Senate considers the bill, possibly in September. Far more remotely, funding could be reinserted in conference. The likelihood of anything more than a continuing resolution being passed to keep the government running after Oct. 1 grows stronger with each passing day, which also moves the program into shutdown mode.Complicating the matter and perhaps offering another avenue of hope for ATP proponents is the possibility of leadership of one or both of the chambers switching political parties with November's election. The lame duck session could be quite lame if the Democrats gain control in January. It is unknown if Democrats would attempt to resurrect the program, however.

ATP was created in 1990 to provide matching funds for industry-led research that accelerates the development of innovative technologies for broad national benefit. ATP has invested in risky, challenging technologies that have the potential for a big payoff for the nation's economy. These technologies create opportunities for new, world-class products, services and industrial processes, benefiting the ATP participants, other companies and industries, and ultimately consumers and taxpayers. By reducing the early-stage R&D risks for individual companies, ATP enables industry to pursue promising technologies which otherwise would be ignored or developed too slowly to compete in rapidly changing world markets.

The Senate Report accompanying H.R. 5672 is available at: http://thomas.loc.gov/home/approp/app07.html

More information on NIST's Advanced Technology Program, including information on the 760-plus projects approved, is available at: http://www.atp.nist.gov/

** Remember, that Tech Collective urges members of the technology industry to not only read and post their thoughts on material we provide in our blog, but to also feel free to post issues and topics of their own for others to respond to.**

Wednesday, July 26, 2006

Charles Nault, CEO of member company Atrion Networking Corporation, featured in Providence Business News


Tech-Collective

Charles L. Nault, Chief Executive Officer of Atrion Networking Corporation and a Tech Collective Board Member and InfoGroup Chairman, was recently featured in various publications for his article entitled, IT Should Always Function As a “Utility.” Mr. Nault is recognized throughout New England for his technical consulting. He has provided training to such renowned companies as Codex Corporation, Avanti Communications, Dynatech Corporation, before starting his own company, Atrion Communications Resources of New England with three other partners. [ More ]

IT Should Always Function As a “Utility” July 13, 2006
by Charles L. Nault

Companies should now expect their IT systems to be available at all times, much like any other basic utility according to an article just published in the Providence Business News, authored by Charles Nault, Chief Executive Officer of Atrion Networking Corporation. "IT has now reached 'utility' status just about everywhere," writes Nault. "Just as the utility of power is required to run your lights, your network infrastructure is required to run your Internet access, and a host of other mission-critical applications that you just cannot function properly without." Nault explains that this mindset not only means that most professionals expect to be able to access the Internet at any time when at the office, but they also expect to access the office server from their home…[ click for entire article ]

Feel free to comment or initiate a discussion regarding your point of view on Mr. Nault’s article or any other issue related to this topic.

Wednesday, July 19, 2006

Tech Collective Blog Launched

Tech-Collective

Another new component to Tech Collective’s new website is the organization’s very own weblog, otherwise known as a “blog”. A blog is an easy-to-use tool where Tech-Collective and its members can post thoughts on particular topics and these topics can be used as an open forum for others to comment. This new addition to the website is yet another way for Tech Collective’s to further its mission in driving technology growth and innovation in Rhode Island.

We encourage you to assist us in the launch of our blog by posting your comments and introducing new technology topics.

Stem Cell Research

Tech-Collective

One of our country’s latest political debates regards the topic of Stem Cell Research. The following are a list of links to a variety of recent articles from various websites that focus on this week’s events in the Senate concerning Stem Cell Research. According to a top story by Peter Urban of The Connecticut Post retrieved from the MSNBC website Tuesday, "Six years into his presidency, President Bush may veto his first bill. The Senate will begin debate today on legislation that would open new avenues for federally funded embryonic stem cell research. If approved, as expected, White House aide Karl Rove said it would be vetoed. In another article featured on MSNBC, “the bill passed by the House last year, as well as the one the Senate will vote on [this] week, permits federal funding for research if the stem cells are: derived from embryos donated by in vitro fertilization clinics; in excess of the need of the individuals seeking fertility treatment; otherwise going to be discarded; and donated by individuals with their written informed consent and without any financial or other inducements. The Senate will also vote on a bill to outlaw the donation of human fetal tissue if a pregnancy was deliberately initiated to provide such tissue and another bill to promote federally-funded research on the therapeutic potential of adult stem cells."

As we now know the Senate voted Tuesday to expand federal funding of embryonic stem cell research. The bill now goes to President Bush for a promised veto. Feel free to peruse the articles and leave your reaction for others to comment on.

REUTERS - Senate backs stem cell bill, Bush to veto
Tue Jul 18, 2006 5:54pm ET By Joanne Kenen
WASHINGTON (Reuters) - The U.S. Senate on Tuesday strongly backed bipartisan legislation to expand federally funded embryonic stem cell research, but President George W. Bush has vowed to veto the measure as morally indefensible. (click on link for full story)
http://today.reuters.com/news/NewsArticle.aspx?type=scienceNews&storyID=2006-07-18T222329Z_01_WAT006064_RTRUKOC_0_US-CONGRESS-STEMCELL.xml


CNN - Senate OKs expansion of stem cell research
Vote, 63-37, not enough to override promised presidential veto (click on link for full story)
http://www.cnn.com/2006/POLITICS/07/18/congress.stemcells.ap/index.html


FOX NEWS - Senate Approves Expanding Funds for Embryonic Stem Cell Research Tuesday, July 18, 2006 WASHINGTON - The Senate passed a bill Tuesday allowing federal funding for embryonic stem cell research. (click on link for full story)http://www.foxnews.com/story/0,2933,204088,00.html


ABC NEWS - Stem Cell Bill Heads for Senate Passage Republicans Try to Stave Off Bush Veto of Stem Cell Bill Being Debated in the Senate By LAURIE KELLMAN WASHINGTON Jul 18, 2006 (AP)- The Senate approved less-controversial stem cell and "fetal farming" bills Tuesday as it sped toward passage of embryonic stem cell legislation that President Bush has promised to veto. (click on link for full story) http://abcnews.go.com/Politics/wireStory?id=2207861

Thursday, April 27, 2006

Hello

Hello Katherine.